Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
Main Authors: | Piotr Ozieranski, Emily Rickard, Shai Mulinari, Marcell Csanádi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e037351.full |
Similar Items
-
Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.
by: Shai Mulinari, et al.
Published: (2020-01-01) -
A hidden web of policy influence: The pharmaceutical industry's engagement with UK's All-Party Parliamentary Groups.
by: Emily Rickard, et al.
Published: (2021-01-01) -
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
by: Alice Fabbri, et al.
Published: (2018-06-01) -
Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
by: Marlene Stoll, et al.
Published: (2020-09-01) -
Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.
by: Anna V Zetterqvist, et al.
Published: (2015-02-01)